Comparison of application of different methods to estimate lifetime cardiovascular risk

被引:6
作者
Brotons, Carlos [1 ,2 ]
Calvo-Bonacho, Eva [3 ]
Moral, Irene [1 ,2 ]
Puig, Mireia [1 ,2 ]
Garcia-Margallo, Maria T. [4 ]
Cortes-Arcas, Maria V. [4 ]
Catalina-Romero, Carlos [3 ]
Quevedo-Aguado, Luis [3 ]
Ruilope, Luis M. [5 ]
机构
[1] Biomed Res Inst Sant Pau IIB Sant Pau, Sardenya Primary Hlth Care Ctr, Res Unit, C Sardenya 466, Barcelona 08025, Spain
[2] Teaching Unit Family Med ACEBA, Barcelona, Spain
[3] Ibermutuamur, Madrid, Spain
[4] Sociedad Prevenc Ibermutuamur, Madrid, Spain
[5] Hosp Univ Doce Octubre, Inst Invest, Madrid, Spain
关键词
Risk assessment; cardiovascular disease; risk factors; ACC/AHA GUIDELINES; DISEASE; PREVENTION; VALIDATION; DERIVATION; IMPACT;
D O I
10.1177/2047487315579616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Recent guidelines recommend assessment of lifetime cardiovascular risk on the basis of traditional risk factors in adults who are not at high short-term risk. The aim of this study is to determine the implications of estimating the lifetime cardiovascular risk in individuals in a large occupational cohort in Spain. Design National cross-sectional study in an occupational cohort with an in-person interview including laboratory tests. Methods Volunteer workers who were examined between January 2011 and December 2011 were included. A total of 580,236 workers were eligible during this year and 259,834 were examined (participation rate of 44.7%). Short-term (10-year) and lifetime cardiovascular risk were estimated using the American College of Cardiology (ACC) and the American Heart Association (AHA) tool and the QRISK2 and QRISK. Results Sixty-eight per cent were male, mean age was 39 years, with an age range of 16 to 75 years. Total number of individuals included in this study was 258,676. The percentage of patients at high short-term risk was 6.85% (95% confidence interval (CI) 6.75%-6.95% and 20.83% (95% CI 20.60%-21.07%) with the QRISK2, and the ACC/AHA risk equations, respectively. Of the percentage of patients classified as not at high risk with the different tools 1.61% (95% CI 1.55%-1.66%) were high lifetime risk on QRISK, and 27.41% (95% CI 27.11%-27.70%) on ACC/AHA risk. Conclusions Application of lifetime cardiovascular risk engages greater numbers of individuals at high risk with substantial differences between the different methods available. These differences can have important clinical implications specifically in the percentage of candidates for lifestyle changes and eventually lipid lowering drugs.
引用
收藏
页码:564 / 571
页数:8
相关论文
共 20 条
[1]  
[Anonymous], 2011, NCD MORT MORB
[2]   Lifetime Risks of Cardiovascular Disease [J].
Berry, Jarett D. ;
Dyer, Alan ;
Cai, Xuan ;
Garside, Daniel B. ;
Ning, Hongyan ;
Thomas, Avis ;
Greenland, Philip ;
Van Horn, Linda ;
Tracy, Russell P. ;
Lloyd-Jones, Donald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :321-329
[3]   Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review [J].
Brindle, P. ;
Beswick, A. ;
Fahey, T. ;
Ebrahim, S. .
HEART, 2006, 92 (12) :1752-1759
[4]   Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study [J].
Calvo-Bonacho, Eva ;
Miguel Ruilope, Luis ;
Angel Sanchez-Chaparro, Miguel ;
Cerezo, Cesar ;
Catalina-Romero, Carlos ;
Martinez-Munoz, Paloma ;
Banegas, Jose R. ;
Waeber, Bernard ;
Gonzalez-Quintela, Arturo ;
Zanchetti, Alberto .
EUROPEAN HEART JOURNAL, 2014, 35 (05) :299-306
[5]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[6]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[7]   Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3) [J].
Deanfield, John ;
Simpson, Iain ;
Bradbury, Kirsten ;
Fox, Keith ;
Boon, Nick ;
Winocour, Peter ;
Feher, Michael ;
Doherty, Patrick ;
Buckley, John ;
Jennings, Catriona ;
Keenan, Jan ;
Weissberg, Peter ;
Knapton, Mike ;
Williams, Bryan ;
Poulter, Neil ;
Stevens, Paul ;
Taal, Maarten ;
Grant, Peter ;
Home, Philip ;
Sattar, Naveed ;
Rees, Alan ;
Neely, Dermot ;
Wheeler, David ;
Goldsmith, David ;
Potter, John ;
Jackson, Stephen .
HEART, 2014, 100 :1-67
[8]   Distribution of short and lifetime risks for cardiovascular disease in Italians [J].
Di Castelnuovo, Augusto ;
Costanzo, Simona ;
Persichillo, Mariarosaria ;
Olivieri, Marco ;
de Curtis, Amalia ;
Zito, Francesco ;
Donati, Maria Benedetta ;
de Gaetano, Giovanni ;
Iacoviello, Licia .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (04) :723-730
[9]  
Goff DC, 2014, CIRCULATION, V129, pS49, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
[10]   An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report [J].
Grundy, Scott M. ;
Arai, Hidenori ;
Barter, Philip ;
Bersot, Thomas P. ;
Betteridge, D. John ;
Carmena, Rafael ;
Cuevas, Ada ;
Davidson, Michael H. ;
Genest, Jacques ;
Kesaniemi, Y. Antero ;
Sadikot, Shaukat ;
Santos, Raul D. ;
Susekov, Andrey V. ;
Sy, Rody G. ;
LaleTokgozoglu, S. ;
Watts, Gerald F. ;
Zhao, Dong .
JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (01) :29-60